I-131 Injection

Generation of iodine-124 for PET imaging applications. Used in thyroid imaging and theranostic procedures.

Diagnostic reagent or control product for nuclear medicine or radiological testing applications.

Diagnostic testing service for evaluation of iodine status as a reference for thyroid nodule assessment. Supports accurate monitoring of iodine-related thyroid conditions.

Diagnostic reagent kits utilizing radioactive tracers for medical imaging and detection of various pathological conditions. Used in nuclear medicine departments for patient diagnosis and monitoring.

Radiopharmaceuticals for diagnostic imaging and therapeutic treatment in nuclear medicine. Includes research, development, manufacturing, and quality assurance services for radiopharmaceutical production under GMP standards, supporting oncology, cardiology, and neurology applications.

Triiodothyronine conjugate for use as a capture reagent in FIA platforms. Used in thyroid hormone immunoassay development.

Production of nitrogen-13 for positron emission tomography imaging agents. Used in cardiac and neurological diagnostic applications.

Production of technetium-99m for SPECT imaging agents. Widely used in nuclear medicine for bone, cardiac, and organ imaging.

A reagent kit for the determination of iodine levels in blood samples. It is used to assess iodine status and monitor thyroid health through serum or plasma iodine measurement.

Complete urine iodine testing solution for assessing iodine deficiency in pregnant women, children, and thyroid patients. Supports reference evaluation for thyroid nodules and health monitoring.

Generation of carbon-11 isotope for PET radiopharmaceutical preparation. Applied in neuroimaging and oncological diagnostic procedures.

Production of zirconium-89 for immuno-PET imaging applications. Supports antibody-based diagnostic imaging in oncology.